Gene Expression Analysis Market Research Report-Forecast till 2030

Gene Expression Analysis Market Research Report: Information by Product (Consumables & Instruments), Service (Gene Expression Profiling & Others), Application (Drug Discovery & Others), End User (Academic, Research Institutes & Others) - Forecast till 2030

ID: MRFR/HC/6335-HCR | August 2022 | Region: Global | 90 Pages         

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Equipment Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Gene Expression Analysis Market, by Product

6.1 Introduction

6.2 Consumables

6.2.1 Reagents

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.2 DNA Chips

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Instruments

6.3.1 Polymerase Chain Reaction (PCR)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.2 Next Generation Sequencing (NGS)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.3 Microarray

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.4 Sanger Sequencing

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.3 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7. Global Gene Expression Analysis Market, by Services

7.1 Introduction

7.2 Gene Expression Profiling Services

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Sequencing Services

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4 Bioinformatics Solutions

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8. Global Gene Expression Analysis Market, by Application

8.1 Introduction

8.2 Drug Discovery

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3 Diagnosis

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Research

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9. Global Gene Expression Analysis Market, by End User

9.1 Introduction

9.2 Pharmaceutical & Biotechnology Companies

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.3 Academic & Research Institutes

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.4 Contract Research Organizations

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.5 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 10. Global Gene Expression Analysis Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 General Electric Company

12.1.1 Company Overview

12.1.2 Products Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Illumina, Inc.

12.2.1 Company Overview

12.2.2 Products Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Thermo Fisher Scientific

12.3.1 Company Overview

12.3.2 Products Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Bio-Rad Laboratories, Inc.

12.4.1 Company Overview

12.4.2 Products Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 F. Hoffmann-La Roche Ltd

12.5.1 Company Overview

12.5.2 Products Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Pacific Biosciences of California, Inc.

12.6.1 Company Overview

12.6.2 Products Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 BGI

12.7.1 Overview

12.7.2 Products Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 PerkinElmer Inc.

12.8.1 Overview

12.8.2 Products Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Agilent Technologies, Inc.

12.9.1 Overview

12.9.2 Products Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 QIAGEN

12.10.1 Overview

12.10.2 Products Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Oxford Gene Technology

12.11.1 Company Overview

12.11.2 Products Overview

12.11.3 Financial Overview

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Eurofins Scientific

12.12.1 Overview

12.12.2 Products Overview

12.12.3 Financial Overview

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 Danaher

12.13.1 Overview

12.13.2 Products Overview

12.13.3 Financials

12.13.4 Key Developments

12.13.5 SWOT Analysis

12.14 Genotypic Technology Pvt Ltd

12.14.1 Overview

12.14.2 Products Overview

12.14.3 Financials

12.14.4 Key Developments

12.14.5 SWOT Analysis

12.15 Macrogen Inc.

12.15.1 Overview

12.15.2 Products Overview

12.15.3 Financials

12.15.4 Key Developments

12.15.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Gene Expression Analysis Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Gene Expression Analysis Market Synopsis, 2020–2027

Table 2 Global Gene Expression Analysis Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Gene Expression Analysis Market, by Region, 2020–2027 (USD Million)

Table 4 Global Gene Expression Analysis Market, by Product, 2020–2027 (USD Million)

Table 5 Global Gene Expression Analysis Market, by Services, 2020–2027 (USD Million)

Table 6 Global Gene Expression Analysis Market, by Applications, 2020–2027 (USD Million)

Table 7 Global Gene Expression Analysis Market, by End User, 2020–2027 (USD Million)

Table 8 North America: Gene Expression Analysis Market, by Product, 2020–2027 (USD Million)

Table 9 North America: Gene Expression Analysis Market, by Services, 2020–2027 (USD Million)

Table 10 North America: Gene Expression Analysis Market, by Applications, 2020–2027 (USD Million)

Table 11 North America: Gene Expression Analysis Market, by End User, 2020–2027 (USD Million)

Table 12 US: Gene Expression Analysis Market, by Product, 2020–2027 (USD Million)

Table 13 US: Gene Expression Analysis Market, by Services, 2020–2027 (USD Million)

Table 14 US: Gene Expression Analysis Market, by Applications, 2020–2027 (USD Million)

Table 15 US: Gene Expression Analysis Market, by End User, 2020–2027 (USD Million)

Table 16 Canada: Gene Expression Analysis Market, by Product, 2020–2027 (USD Million)

Table 17 Canada: Gene Expression Analysis Market, by Services, 2020–2027 (USD Million)

Table 18 Canada: Gene Expression Analysis Market, by Applications, 2020–2027 (USD Million)

Table 19 Canada: Gene Expression Analysis Market, by End User, 2020–2027 (USD Million)

Table 20 South America: Gene Expression Analysis Market, by Product, 2020–2027 (USD Million)

Table 21 South America: Gene Expression Analysis Market, by Services, 2020–2027 (USD Million)

Table 22 South America: Gene Expression Analysis Market, by Applications, 2020–2027 (USD Million)

Table 23 South America: Gene Expression Analysis Market, by End User, 2020–2027 (USD Million)

Table 24 Europe: Gene Expression Analysis Market, by Product, 2020–2027 (USD Million)

Table 25 Europe: Gene Expression Analysis Market, by Services, 2020–2027 (USD Million)

Table 26 Europe: Gene Expression Analysis Market, by Applications, 2020–2027 (USD Million)

Table 27 Europe: Gene Expression Analysis Market, by End User, 2020–2027 (USD Million)

Table 28 Western Europe: Gene Expression Analysis Market, by Product, 2020–2027 (USD Million)

Table 29 Western Europe: Gene Expression Analysis Market, by Services, 2020–2027 (USD Million)

Table 30 Western Europe: Gene Expression Analysis Market, by Applications, 2020–2027 (USD Million)

Table 31 Western Europe: Gene Expression Analysis Market, by End User, 2020–2027 (USD Million)

Table 32 Eastern Europe: Gene Expression Analysis Market, by Product, 2020–2027 (USD Million) Table 33 Eastern Europe: Gene Expression Analysis Market, by Services, 2020–2027 (USD Million)

Table 34 Eastern Europe: Gene Expression Analysis Market, by Applications, 2020–2027 (USD Million)

Table 35 Eastern Europe: Gene Expression Analysis Market, by End User, 2020–2027 (USD Million)

Table 36 Asia-Pacific: Gene Expression Analysis Market, by Product, 2020–2027 (USD Million) Table 37 Asia-Pacific: Gene Expression Analysis Market, by Services, 2020–2027 (USD Million)

Table 38 Asia-Pacific: Gene Expression Analysis Market, by Applications, 2020–2027 (USD Million)

Table 39 Asia-Pacific: Gene Expression Analysis Market, by End User, 2020–2027 (USD Million)

Table 40 Middle East & Africa: Gene Expression Analysis Market, by Product, 2020–2027 (USD Million)

Table 41 Middle East & Africa: Gene Expression Analysis Market, by Services, 2020–2027 (USD Million)

Table 42 Middle East & Africa: Gene Expression Analysis Market, by Applications, 2020–2027 (USD Million)

Table 43 Middle East & Africa: Gene Expression Analysis Market, by End User, 2020–2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure for Global Gene Expression Analysis Market

Figure 3 Market Dynamics for Global Gene Expression Analysis Market

Figure 4 Global Gene Expression Analysis Market Share, by Product, 2020

Figure 5 Global Gene Expression Analysis Market Share, by Services, 2020

Figure 6 Global Gene Expression Analysis Market Share, by Applications, 2020

Figure 7 Global Gene Expression Analysis Market Share, by End User, 2020

Figure 8 Global Gene Expression Analysis Market Share, by Region, 2020

Figure 9 North America: Gene Expression Analysis Market Share, by Country, 2020

Figure 10 Europe: Gene Expression Analysis Market Share, by Country, 2020

Figure 11 Asia-Pacific: Gene Expression Analysis Market Share, by Country, 2020

Figure 12 Middle East & Africa: Gene Expression Analysis Market Share, by Country, 2020

Figure 13 Global Gene Expression Analysis Market: Company Share Analysis, 2020 (%)

Figure 14 GENERAL ELECTRIC COMPANY: Key Financials

Figure 15 GENERAL ELECTRIC COMPANY: Segmental Revenue

Figure 16 GENERAL ELECTRIC COMPANY: Geographical Revenue

Figure 17 Illumina, Inc.: Key Financials

Figure 18 Illumina, Inc.: Segmental Revenue

Figure 19 Illumina, Inc.: Geographical Revenue

Figure 20 THERMO FISHER SCIENTIFIC: Key Financials

Figure 21 THERMO FISHER SCIENTIFIC: Segmental Revenue

Figure 22 THERMO FISHER SCIENTIFIC: Geographical Revenue

Figure 23 Bio-Rad Laboratories, Inc.: Key Financials

Figure 24 Bio-Rad Laboratories, Inc.: Segmental Revenue

Figure 25 Bio-Rad Laboratories, Inc.: Geographical Revenue

Figure 26 F. Hoffmann-La Roche Ltd: Key Financials

Figure 27 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 28 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 29 Pacific Biosciences of California, Inc.: Key Financials

Figure 30 Pacific Biosciences of California, Inc.: Segmental Revenue

Figure 31 Pacific Biosciences of California, Inc.: Geographical Revenue

Figure 32 BGI: Key Financials

Figure 33 BGI: Segmental Revenue

Figure 34 BGI: Geographical Revenue

Figure 35 PerkinElmer Inc.: Key Financials

Figure 36 PerkinElmer Inc.: Segmental Revenue

Figure 37 PerkinElmer Inc.: Geographical Revenue

Figure 38 Agilent Technologies, Inc.: Key Financials

Figure 39 Agilent Technologies, Inc.: Segmental Revenue

Figure 40 Agilent Technologies, Inc.: Geographical Revenue

Figure 41 QIAGEN: Key Financials

Figure 42 QIAGEN: Segmental Revenue

Figure 43 QIAGEN: Geographical Revenue

Figure 44 Oxford Gene Technology: Key Financials

Figure 45 Oxford Gene Technology: Segmental Revenue

Figure 46 Oxford Gene Technology: Geographical Revenue

Figure 47 Eurofins Scientific: Key Financials

Figure 48 Eurofins Scientific: Segmental Revenue

Figure 49 Eurofins Scientific: Geographical Revenue

Figure 50 Danaher: Key Financials

Figure 51 Danaher: Segmental Revenue

Figure 52 Danaher: Geographical Revenue

Figure 53 Genotypic Technology Pvt Ltd: Key Financials

Figure 54 Genotypic Technology Pvt Ltd: Segmental Revenue

Figure 55 Genotypic Technology Pvt Ltd: Geographical Revenue

Figure 56 Macrogen Inc.: Key Financials

Figure 57 Macrogen Inc.: Segmental Revenue

Figure 58 Macrogen Inc.: Geographical Revenue

Gene Expression Analysis Market

Gene Expression Analysis Market is expected to grow USD 7362.06 million at a 10.30% CAGR From 2020-2030.

Segmentation

By Product Consumables Instruments
By Service Gene Expression Profiling Services Sequencing Services Bioinformatics Solutions Others
By Application Drug Discovery Diagnosis Research Others
By End User Pharmaceutical & Biotechnology Companies Academic & Research Institutes Contract Research Organizations Others

Key Players

  • GENERAL ELECTRIC COMPANY
  • Illumina
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche Ltd
  • Pacific Biosciences of California
  • BGI
  • PerkinElmer Inc.
  • Agilent Technologies

Drivers

  • Increasing research into genetics to understand the root causes of various diseases.
Speak to Analyst Request a Free Sample

Gene Expression Analysis Market Overview
 
Gene Expression Analysis Market will show a steady growth rate in the forecast period. It will reach a valuation of USD 7362.06 million and register a CAGR of 10.30 % during the forecast period by 2030. 
 
Gene expression analysis is research for functional genomics to apply and study genes and gene transcripts. Synthesizing applicable gene products like functional RNAs and protein species will lead to intact organisms surviving when a gene goes missing. Growth in advanced medicine and technological developments is accelerating the market's growth. The growing development of genomic databases is a key growth factor, along with the increased rate of investment in genomics will fuel the market's growth.
 
The cost reduction in sequencing will offer vast opportunities for stakeholders in the healthcare sector. For instance, affordable sequencing will enable researchers to sequence the genomes of thousands of individuals, which will lead to improved data for the identification of illnesses and their causes. This will also allow individuals with rare diseases to be treated immediately. Therefore, cost reduction of sequencing will be a major driver of the market.
Active collaboration for the improvement of healthcare quality and the advancement in domestic biotechnology sectors, along with the rise of government funding for research, is the enhancing factors that provide huge growth opportunities to the industrial players of the gene expression analysis market.

Segmentation


The gene expression analysis market has been segmented into product, services, application, end-user, and region.


The market, on the basis of product, has been segmented into consumables and instruments.


The market, based on consumables, has been further segmented into reagents and DNA chips.


The market, based on instruments, has been further segmented into polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray, Sanger sequencing, and others.


The market, by services, has been segmented into gene expression profiling services, sequencing services, bioinformatics solutions, and others.


The market, by application, has been segmented into drug discovery, diagnosis, research, and others.


The market, by end-user, has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, and others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The gene expression analysis market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European gene expression analysis market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The gene expression analysis market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The gene expression analysis market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key Players


GENERAL ELECTRIC COMPANY, Illumina, Inc., Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Pacific Biosciences of California, Inc., BGI, PerkinElmer Inc., Agilent Technologies, Inc., QIAGEN, Oxford Gene Technology, Eurofins Scientific, Danaher, Genotypic Technology Pvt Ltd, Macrogen Inc. are some of the key players in the global gene expression analysis market.


Regional Market Summary


Global Gene Expression Analysis Market Share (%), by Region, 2017Global Gene Expression Analysis Market Share, by Region, 2017

Source: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC)


Geographically, the Americas is anticipated to dominate the global gene expression analysis market owing to the increasing research activities and the rising popularity of gene expression tests. Additionally, the well-developed healthcare sector is anticipated to boost the American gene expression analysis market.


Europe is expected to hold the second largest position in the global gene expression analysis market. The market growth in this region is attributed to the availability of funds for research.


Asia-Pacific is anticipated to be the fastest growing region in the market due to the growing investment from governments in the field of genomics, and continuously developing economies. According to a report published by the International Journal of Social and Developmental Concerns in October 2017, in Malaysia, the growth of the public primary, as well as secondary care facilities, has decreased in the past few years, and it has not kept pace with the rapid urbanization. Thus, such factors restraint the growth of the market in this region. On the other hand, the Middle East & Africa has the least share of the market.


Global Gene Expression Analysis Market, by Product



  • Consumables

    • Reagents

    • DNA Chips



  • Instruments

    • Polymerase Chain Reaction (PCR)

    • Next Generation Sequencing (NGS)

    • Microarray

    • Sanger Sequencing

    • Others




Global Gene Expression Analysis Market, by Service



  • Gene Expression Profiling Services

  • Sequencing Services

  • Bioinformatics Solutions

  • Others


Global Gene Expression Analysis Market, by Application



  • Drug Discovery

  • Diagnosis

  • Research

  • Others


Global Gene Expression Analysis Market, by End User



  • Pharmaceutical & Biotechnology Companies

  • Academic & Research Institutes

  • Contract Research Organizations

  • Others


Global Gene Expression Analysis Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Global Gene Expression Analysis Market, by Key Players



  • GENERAL ELECTRIC COMPANY

  • Illumina, Inc.

  • Thermo Fisher Scientific

  • Bio-Rad Laboratories, Inc.

  • Hoffmann-La Roche Ltd

  • Pacific Biosciences of California, Inc.

  • BGI, PerkinElmer Inc.

  • Agilent Technologies, Inc.

  • QIAGEN

  • Oxford Gene Technology

  • Eurofins Scientific

  • Danaher

  • Genotypic Technology Pvt Ltd

  • Macrogen Inc.


Recent Development


In May 2022


ODA Biotherapeutics, Inc., a biopharmaceutical company is developing a gene therapy chemogenetic platform for treating intractable neurological disorders, has announced that preclinical data from the Company's focal epilepsy program will be featured at the American Society of Gene & Cell Therapy 25th Annual Meeting being held virtually and in-person, May 16-19, 2022, in Washington, D.C. 


CODA's approach for treating focal epilepsy is adeno-associated virus-mediated delivery of a novel engineered ligand-gated ion channel (LGIC) that can respond to an exogenous ligand. Oral administration of this small molecule ligand, which is designed to only interact with CODA's chimeric LGIC, is tuned to control the aberrant activity of neurons and suppress seizures.

Intended Audience



  • Biotechnology Companies

  • Diagnostic Laboratories

  • Government Research Institute

  • Academic Institutes and Universities



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 7362.06 million
  CAGR   2020-2030: 10.30%
  Base Year   2020
  Forecast Period   2030
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Services, Application, End-User and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   GENERAL ELECTRIC COMPANY, Illumina, Inc., Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Pacific Biosciences of California, Inc., BGI, PerkinElmer Inc., Agilent Technologies, Inc., QIAGEN, Oxford Gene Technology, Eurofins Scientific, Danaher, Genotypic Technology Pvt Ltd, Macrogen Inc.
  Key Market Opportunities   Research Activities
  Key Market Drivers   Increasing research into genetics to understand the root causes of various diseases.


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The global gene expression analysis market is expected to rise to a valuation of USD 7326.06 million over the forecast period from 2020 to 2030.

The global market is expected to exhibit a stable 10.30% CAGR over the forecast period.

The increasing research into genetics to understand the root causes of various diseases is the major driver for the global gene expression analysis market.

North America is the leading regional market.

Leading players in the market include F. Hoffman-La Roche, Thermo Fisher Scientific, Macrogen, Illumina, and Danaher, among others.